Partners in Digital Health | Podcast in RSS.com

Partners in Digital Health

Partners in Digital Health

di Tory Cenaj

Medicina Notizie informatiche Tecnologia

Stagione 8

The Last Mile: Why 90% of Biomedical AI Research is Stuck

The Last Mile: Why 90% of Biomedical AI Research is Stuck Stephen Dennis CTO, Softhread Dr. Bob Rogers Co-founder and Chief Scientific Officer, BeeKeeperAI Over 90% of all biomedical AI research is stalled due to its inability to access real world protected health information to complete the required clinical validation and valuation prior to its deployment. With AI forecasted to improve patient outcomes by 40% and costs by 50% the new paradigm of zero trust must be adopted and leveraged to avoid the existential crisis facing biomedical AI research. Join us and learn how confidential computing and blockchain meet the requirements of zero trust.

Economic, Regulatory and Cultural Reasons Why Decentralized Health is More Successful in EMDE

What Elements of Blockchain Tech Can Healthcare Benefit from TODAY Without Committing to Decentralization

What Elements of Blockchain Tech Can Healthcare Benefit from TODAY Without Committing to Decentralization Bart Cant - CTO, Tydei.io John Hatchell - Co-Founder and Chief Executive Officer, Tydei.io Speakers discuss: The strategy for utilizing DAML for the purpose of progressive decentralization in enterprise Converging how TradFi was brought on chain to innovate healthcare payments Future strategies utilizing DAO’s and NFT’s in a heavily regulated environment

Open DLT for Patient Privacy Protection in the Age of Healthcare Consumerism

Open DLT for Patient Privacy Protection in the Age of Healthcare Consumerism Maria Palombini Director, Healthcare & LIfe Science Global Practice Lead, IEEE SA Sachin Shetty Associate Director , Virginia Modeling, Analysis and Simulation Center (VMASC), Old Dominion University, and Executive Director of the Center for Secure and Intelligent Critical Systems Daniel Harrell, PhD Research Associate, Department of Population Health, Dell Medical School, University of Texas at Austin Key discussion points of this panel session include: The role of open source DLTs in empowering and protecting patients data The role of where technical and data standards are pragmatically needed The technical and ethical considerations of patient data governance

What Comes After Predictions: A Deep Dive on Healthcare’s Next Moves

Ajaz S. Hussain Strategic Advisor, Bright Path Laboratories, and BHTY Editor Michael Dershem CEO, Apierion Jim Nasr CEO, Acoer, and BHTY Editor John Riley III Chief of Emerging Tech, IMPACTIFI • Mohan Venkataraman Principal Consultant, Block10.ai We gathered the authors of BHTY’s “2026 Healthcare Predictions: AI, Blockchain, and the Rise of Decentralized Innovation,” for a video and podcast conversation to unpack the forces redefining healthcare’s future. The follow-up discussion moved beyond predictions into real-world implications, adoption hurdles, and execution risks across healthcare: Blockchain, Trust, and Claims Management Insights into how decentralized architectures can improve trust, reduce claims friction, and create more transparent interactions among patients, payers, and providers. Patient Agency and Health Data Sovereignty A focused discussion on decentralized identity, privacy-preserving data sharing, and the growing global shift toward patient-controlled health data. AI + Blockchain in the Supply Chain Use cases in pharmaceutical and healthcare supply chains—including supplier verification, smart tags for condition monitoring, and the push for traceability and resiliency. Decentralized Science (DeSci) How decentralized funding and peer review models are addressing bottlenecks in clinical research, preclinical discovery, and scientific collaboration. AI Risk, Safety, and Centralization Concerns The panel addressed the unintended consequences of centralized health AI, emphasizing governance, bias mitigation, and regulatory alignment. Payments, Digital Assets, and Readiness for 2026 A candid look at healthcare payment dysfunction, the role of digital assets and stablecoins, and why CXOs are beginning to engage seriously with these models. Watch or listen to the conversation for extended analysis and candid perspectives from leaders working at the front lines of decentralized healthcare innovation. More conversations will be featured at the annual ConV2X Decentralized Healthcare & Life Sciences Summit this September - where these themes move from theory to implementation. Early Bird Registration is open at https://conv2xsymposium.com/cart

Safe AI for Healthcare

Safe AI for Healthcare Jim Nasr CEO, Acoer Jelani Clarke, PhD Executive Lead at DeSci World, and Sales & Marketing Head at AminoChain Owais Durrani. MD Memorial Hermann Health System The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) brought together three pioneers at the intersection of medicine and decentralized technology for a candid conversation about what safe AI means for healthcare and how to make it so – including best practices. Themes addressed include: What is Safe AI? Data Sovereignty in Healthcare: who owns the AI model and its memory? Where does decentralization fit? How will it help reduce AI risk? What is next? This conversation is the second in a new podcast series launched in 2026 that dives into the decentralized science revolution.

From Innovation to Evidence: Publish What You've Proven

From Innovation to Evidence: Publish What You've Proven Paul Barach, PhD Principal, J. Bara Innovation; Chief Medical Officer, Pegwin, and THMT Associate Editor-in-Chief Sandeep Bhat, MSE Former Senior Leader, Digital Engagement, Global Clinical Operations, GSK; Principal, Visualized Ventures, and THMT Editor Liam William C. B. Harding, PhD Professor, Trine University, NSF Reviewer, Medtronic Distinguished Technical Fellow; and THMT Section Editor This new podcast series explores real world research, its value, and enterprise perspectives on the topic. If you are deploying digital health solutions running pilots, generating real world outcomes, or tracking what works and what doesn't, you may find this series of particular interest. If work lives only in internal dashboards and slide decks, it's invisible to the clinicians, payers, regulators, and partners who need it most - those creating, building, developing solutions that transform real world practice and clinical applications. Whether you work in pharma, a health plan, a digital health startup, or a health system—this will explain why publishing is now a strategic imperative, not just an academic exercise. Regulators, payers, and health systems are demanding proof. Coverage decisions, partnership deals, and procurement conversations increasingly hinge on published evidence. WHAT YOU'LL LEARN What types of enterprise work qualify as publishable research (more than you think) Why THMT is built for real world, practitioner led evidence—not just academic studies How pharma, payers, and startups each benefit from publishing How to overcome the most common barriers: time, legal concerns, and "we're not academics" What editors are actively looking for right now—and how to get started

Medical Device Cybersecurity Standards: Raising the Bar for Patient Safety

Medical Device Cybersecurity Standards: Raising the Bar for Patient Safety Naomi Schwartz - Vice President, Regulatory Strategy, Medcrypt Elizabeth Baker, PhD - Professor of Information Systems at Virginia Commonwealth University, and THMT Academic & Research Integrity Oversight Maria Palombini - Director, Healthcare & Life Sciences Global Practice Lead, IEEE Standards Association As healthcare becomes increasingly connected, medical device cybersecurity is no longer an IT issue — it is a patient safety imperative. In this expert discussion, three leaders at the intersection of regulation, standards, and innovation explore why cybersecurity must be embedded into the DNA of medical device design from day one. Topics include: Standards and Innovation — Raising the Bar Purpose Driven Functionality & Protecting Patients Predictability & Security in Procurement Designing with Standards from the Start Medical Devices in Patient Care Settings FDA’s VEX Data & Quality Management Systems Cybersecurity = Patient Safety Be Proactive. Participate. Lead. For more information on this subject visit: Cybersecurity and Healthcare at DOI: https://doi.org/10.30953/thmt.v10.652 Cybersecurity for Medical Device Certification video here

Publishing Where It Matters: A Candid Conversation

Publishing Where It Matters: A Candid Conversation Paul Barach, MD, MPH THMT Associate Editor; Thomas Jefferson University, Principal at J. Bara Innovation, and Chief Medical Officer, Pegwin https://orcid.org/0000-0002-7906-698X Dr. Suhail Chughtai, FRCS, FFLM Clinical Director of Orthopaedics & Trauma, M L Professionals, London, UK, and AI Division Head, United Kingdom Digital Health & Care, UK - THMT Co-Editor-in-Chief https://orcid.org/0009-0009-7639-2833 Martin Curley, PhD Professor of Innovation at Maynooth University, Director of the Digital Health Ecosystem at the Innovation Value Institute, and a visiting professor at the University of Bath, Ireland - THMT Co-Editor-in-Chief In a refreshingly open and candid podcast conversation, new Editors-in-Chief of Telehealth and Medicine Today (THMT) sat down to talk honestly about where the journal stands, where it is headed, and why they believe it occupies a genuinely distinct and necessary place in the scholarly landscape. The conversation was a frank dialogue among colleagues who care deeply about the field and want researchers to understand both the journal's purpose and its current realities. Catch every podcast episode on your favorite podcast platform and subscribe on YouTube, Apple Podcasts, Spotify.

The Real Economics of Value Based Care

The Real Economics of Value Based Care Erik Johnson Senior Vice President and National Practice Lead, Value Based Care, Optum Lyle Berkowitz, MD Founder and Chairman, KeyCare and Editor-in-Chief, THMT Is value based care truly aligning incentives — or redistributing financial risk across payers, providers, and patients in ways that compress margins and shift burden? Is telehealth a costsaving lever under properly structured risk contracts — or perceived as a margin threat? At a time when value based care dominates policy rhetoric, this episode moves past theory and into financial reality. This discussion directly examines whether value based care is delivering on its economic promise — or simply reshuffling financial risk across the system. This episode also addresses the deeper economic tension beneath the surface: Who wins, who loses, and who is subsidizing whom?

1 di 31